Massachusetts General Hospital

BiographyAditya Bardia MD, MPH, completed his Internal Medicine residency training at Mayo Clinic and oncology fellowship at Johns Hopkins Kimmel Cancer Center. Dr. Bardia is interested in developing predictive biomarkers and algorithms to maximize efficacy and minimize harms of therapeutic agents and thus personalize therapies for breast cancer. This includes evaluation of large databases to identify potential biomarkers, as well as conduct of biomarker driven clinical trials to evaluate blood based biomarkers (such as circulating tumor cells) and tissue based biomarkers (such as gene signatures) to predict response (or lack thereof) of a particular chemotherapy or targeted therapy. Dr. Bardia is the recipient of Young Investigator Award from the ASCO Conquer Cancer Foundation.

Publications

View my most recent publications at PubMed

1. 1. Bardia A, Hartmann LC, et al. Leisure time physical activity & risk of postmenopausal breast cancer. Arch Intern Med. 2006;166:2478-83.
2. 2. Bardia A, Barton DL, et al. Efficacy of complementary & alternative medicine therapies in relieving cancer pain: Systematic Review. J Clin Oncol. 2006;24:5457-64.
3. 3. Bardia A, Ebbert JO, et al. Association of aspirin & other NSAID use with cancer incidence and mortality among post menopausal women. J Natl Cancer Inst. 2007;99(11):881-9.
4. 4. Bardia A, Stearns V. Personal Breast. Breast Cancer Res Treat. Editorial. 2010;120(2):437-9.
5. 5. Bardia A, Stearns V. Personalized Tamoxifen. Clin Cancer Res. Editorial. 2010;16(17):4308-10.